Divyaswathi Citla Sridhar and Team Report Higher VTE Rates in Obese Users of Certain Estrogen-Progestin Combinations
RPTH Journal shared on LinkedIn:
”Does obesity amplify clot risk with hormonal therapy?
A massive database study from Divyaswathi Citla Sridhar, MD MS and team reports higher VTE rates in obese users of certain estrogen-progestin combinations—but not with progesterone-only therapy.
Curious which regimens carry the greatest risk?
Co-authors: Madhvi Rajpurkar, Lakshmi Srivaths, Bethany Samuelson Bannow, Rachel Rosovsky, and Nancy Sokkary”
Read the full article in RPTH.
Article: Venous thromboembolism in obese hormonal contraceptive users: a large national database study
Authors: Divyaswathi Citla-Sridhar, Madhvi Rajpurkar, Lakshmi Srivaths, Bethany Samuelson Bannow, Rachel P. Rosovsky, Nancy Sokkary
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 30, 2025, 13:23Ditte Vestergaard Hansen and Colleagues on Predictors of VTE Post-Stroke
-
Nov 30, 2025, 12:40Timos Papagatsias: Interested in Social Media in the Hematology Space?
-
Nov 30, 2025, 12:15Raphaël Liévin: In March 2026 SFH Will Host Its Very First Young EHA Research Meeting (YERM)!
-
Nov 30, 2025, 11:51Mohamed Aly Saad Aly on Microcatheters for Superselective Arterial Embolization
-
Nov 29, 2025, 18:55Ahmad Thuaimer: Success Story – Advanced Interventional Care for DVT
-
Nov 29, 2025, 17:37Almahdi Ali Explores Ipsilateral Paradoxical Thromboembolism at 22nd European Angiology Days 2025
-
Nov 29, 2025, 17:23Jack Shuang Hou Shares Major Neurology Updates This Week
-
Nov 29, 2025, 16:52Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
-
Nov 29, 2025, 16:42Dr Abdul Mannan on the Echinocyte: Mastering the Diagnostic Duality of Artifact vs. Pathology